Our Neuromuscular Panel offers advanced genetic testing for patients presenting with muscular diseases. This comprehensive panel includes genes associated with a wide range of neurological disorders, covering:
355
30 Business Days
≥99.00% ≥20x
NGS including CNV Analysis, Repeat Expansion Analysis (DMPK), MLPA (SMN1, SMN2)
MLPA targeted to the DMD gene for Duchenne Muscular Dystrophy (recommended for high diagnostic suspicion)
Sample Requirements:
Coverage:
Discover our advanced genomic testing services tailored for your specific needs. Contact us today to enhance your research with unparalleled accuracy and expertise.
Get The Latest Updates via email. Any time you may unsubscribe
Copyright © 2024 Zarqa Genomics Lab, All rights reserved